Agency Information Collection Activities: Proposed Collection; Comment Request, 60403-60404 [2022-21657]
Download as PDF
60403
Federal Register / Vol. 87, No. 192 / Wednesday, October 5, 2022 / Notices
research. The total cost burden is
estimated to be $6,218 annually.
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Activity
Number of
respondents
Number of
responses per
respondent
Hours per
response
Total
burden hours
COVID–19 questions included in the MEPS questionnaire ............................
13,338 *
1
1/60
222
* While the expected number of responding units for the annual estimates is 12,804, it is necessary to adjust for survey attrition of initial respondents by a factor of 0.96 (13.338=12/804/0.96).
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Activity
Number of
respondents
Total
burden hours
Average
hourly wage
rate *
Total cost
burden
COVID–19 questions included in the MEPS questionnaire ............................
13,338
222
$28.01
$6,218
* Based upon mean hourly wage, ‘‘May 2021 National Occupational Employment and Wage Estimates United States,’’ U.S. Department of
Labor, Bureau of Labor Statistics, retrieved at https://www.bls.gov/oes/current/oes_nat.htm#00-0000.
Request for Comments
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3520,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) whether the
proposed collection of information is
necessary for the proper performance of
AHRQ’s health care research and health
care information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: September 29, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022–21624 Filed 10–4–22; 8:45 am]
jspears on DSK121TN23PROD with NOTICES
BILLING CODE 4160–90–P
VerDate Sep<11>2014
18:05 Oct 04, 2022
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10260 & CMS–
10142]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
December 5, 2022.
SUMMARY:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number:ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
E:\FR\FM\05OCN1.SGM
05OCN1
60404
Federal Register / Vol. 87, No. 192 / Wednesday, October 5, 2022 / Notices
jspears on DSK121TN23PROD with NOTICES
CMS–10260—Medicare Advantage and
Prescription Drug Program: Final
Marketing Provisions in 42 CFR
422.111(a)(3) and 423.128(a)(3).
CMS–10142—Bid Pricing Tool (BPT) for
Medicare Advantage (MA) Plans and
Prescription Drug Plans (PDP).
Under the PRA (44 U.S.C. 3501–
3520), Federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare
Advantage and Prescription Drug
Program: Final Marketing Provisions in
42 CFR 422.111(a)(3) and 423.128(a)(3);
Use: CMS requires MA organizations
and Part D sponsors to use the
standardized documents being
submitted for OMB approval to satisfy
disclosure requirements mandated by
section 1851 (d)(3)(A) of the Act and
§ 422.111 for MA organizations and
section 1860D–1(c) of the Act and
§ 423.128(a)(3) for Part D sponsors.
The regulatory provisions at
§§ 422.111(b) and 423.128(b) require
MA organizations and Part D sponsors
to disclose plan information, including:
service area, benefits, access, grievance
and appeals procedures, and quality
improvement/assurance requirements.
MA organizations and sponsors may
send the ANOC separately from the
EOC, but must send the ANOC for
enrollee receipt by September 30. The
required due date for the EOC is 15 days
prior to the start of the AEP.
CMS requires MA organization and
Part D sponsors to submit marketing
materials to CMS for review prior to the
MA organization or sponsor distributing
those materials to the public. In section
1851(h), paragraphs (1), (2), and (3)
establish this requirement for MA
organizations. Section 1860D–
1(b)(1)(B)(vi) directs Part D sponsors to
VerDate Sep<11>2014
18:05 Oct 04, 2022
Jkt 259001
follow the same requirements in section
1851(h) that MA organizations must
follow for this purpose. Form number:
CMS–10260 (OMB control number:
0938–1051); Frequency: Annually;
Affected Public: State, Local, or Tribal
Governments; Number of Respondents:
800; Number of Responses: 48,439;
Total Burden Hours: 33,419.50. (For
questions regarding this collection
contact Elizabeth Jacob at 410–786–
8658).
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Bid Pricing Tool
(BPT) for Medicare Advantage (MA)
Plans and Prescription Drug Plans
(PDP); Use: Medicare Advantage
organizations (MAO) and Prescription
Drug Plans (PDP) are required to submit
an actuarial pricing ‘‘bid’’ for each plan
offered to Medicare beneficiaries for
approval by CMS. The MAOs and PDPs
use the Bid Pricing Tool (BPT) software
to develop their actuarial pricing bid.
The competitive bidding process
defined by the ‘‘The Medicare
Prescription Drug, Improvement, and
Modernization Act’’ (MMA) applies to
both the MA and Part D programs. It is
an annual process that encompasses the
release of the MA rate book in April, the
bid’s that plans submit to CMS in June,
and the release of the Part D and RPPO
benchmarks, which typically occurs in
August. Form number: CMS–10142
(OMB control number: 0938–0944);
Frequency: Annually; Affected Public:
Private Sector, Business or other forprofits, Not-for-profit institutions;
Number of Respondents: 555; Number
of Responses: 4,995; Total Burden
Hours: 149,850. (For questions regarding
this collection contact Rachel Shevland
at 410–786–3026).
Dated: September 30, 2022.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2022–21657 Filed 10–4–22; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Blood and Tissue Safety and
Availability
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
AGENCY:
ACTION:
PO 00000
Notice.
Frm 00040
Fmt 4703
Sfmt 4703
The U.S. Department of
Health and Human Services is hereby
giving notice that the Advisory
Committee on Blood and Tissue Safety
and Availability (ACBTSA) will hold a
virtual meeting. The meeting will be
open to the public via webcast. The
committee will discuss and vote on a
recommendation related to the
implementation of the HIV Organ Policy
Equity (HOPE) Act of 2013, pertaining
to HIV-positive to HIV-positive organ
transplantation.
DATES: The meeting will take place
virtually on Thursday, November 17,
2022 from approximately 10 a.m.–3 p.m.
eastern time (ET). Meeting times are
tentative and subject to change. The
confirmed times and agenda items for
the meeting will be posted on the
ACBTSA web page at https://
www.hhs.gov/oidp/advisory-committee/
blood-tissue-safety-availability/
meetings/2022-11-17/ when
this information becomes available.
FOR FURTHER INFORMATION CONTACT:
James Berger, Designated Federal Officer
for the ACBTSA; Office of Infectious
Disease and HIV/AIDS Policy, Office of
the Assistant Secretary for Health,
Department of Health and Human
Services, Tower Building, 1101 Wootton
Parkway, Rockville, MD 20852. Email:
ACBTSA@hhs.gov. Phone: 202–795–
7608.
SUPPLEMENTARY INFORMATION: On the
day of the meeting, please go to https://
www.hhs.gov/live/ to view
the meeting. The public will have an
opportunity to present their views to the
ACBTSA by submitting a written public
comment. Comments should be
pertinent to the meeting discussion.
Persons who wish to provide written
public comment should review
instructions at https://www.hhs.gov/
oidp/advisory-committee/blood-tissuesafety-availability/meetings/2022-11-17/
index.html and respond by midnight
November 9, 2022, ET. Written public
comments will be accessible to the
public on the ACBTSA web page prior
to the meeting.
Background and Authority: The
ACBTSA is a discretionary Federal
advisory committee and is governed by
the provisions of the Federal Advisory
Committee Act (FACA), Public Law 92–
463, as amended (5 U.S.C. app), which
sets forth standards for the formation
and use of advisory committees. The
ACBTSA functions to provide advice to
the Secretary through the Assistant
Secretary for Health on a range of policy
issues to include: (1) Identification of
public health issues through
surveillance of blood and tissue safety
issues with national survey and data
SUMMARY:
E:\FR\FM\05OCN1.SGM
05OCN1
Agencies
[Federal Register Volume 87, Number 192 (Wednesday, October 5, 2022)]
[Notices]
[Pages 60403-60404]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21657]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10260 & CMS-10142]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), Federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including the necessity and utility of the
proposed information collection for the proper performance of the
agency's functions, the accuracy of the estimated burden, ways to
enhance the quality, utility, and clarity of the information to be
collected, and the use of automated collection techniques or other
forms of information technology to minimize the information collection
burden.
DATES: Comments must be received by December 5, 2022.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number:__, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
[[Page 60404]]
CMS-10260--Medicare Advantage and Prescription Drug Program: Final
Marketing Provisions in 42 CFR 422.111(a)(3) and 423.128(a)(3).
CMS-10142--Bid Pricing Tool (BPT) for Medicare Advantage (MA) Plans and
Prescription Drug Plans (PDP).
Under the PRA (44 U.S.C. 3501-3520), Federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicare
Advantage and Prescription Drug Program: Final Marketing Provisions in
42 CFR 422.111(a)(3) and 423.128(a)(3); Use: CMS requires MA
organizations and Part D sponsors to use the standardized documents
being submitted for OMB approval to satisfy disclosure requirements
mandated by section 1851 (d)(3)(A) of the Act and Sec. 422.111 for MA
organizations and section 1860D-1(c) of the Act and Sec. 423.128(a)(3)
for Part D sponsors.
The regulatory provisions at Sec. Sec. 422.111(b) and 423.128(b)
require MA organizations and Part D sponsors to disclose plan
information, including: service area, benefits, access, grievance and
appeals procedures, and quality improvement/assurance requirements. MA
organizations and sponsors may send the ANOC separately from the EOC,
but must send the ANOC for enrollee receipt by September 30. The
required due date for the EOC is 15 days prior to the start of the AEP.
CMS requires MA organization and Part D sponsors to submit
marketing materials to CMS for review prior to the MA organization or
sponsor distributing those materials to the public. In section 1851(h),
paragraphs (1), (2), and (3) establish this requirement for MA
organizations. Section 1860D-1(b)(1)(B)(vi) directs Part D sponsors to
follow the same requirements in section 1851(h) that MA organizations
must follow for this purpose. Form number: CMS-10260 (OMB control
number: 0938-1051); Frequency: Annually; Affected Public: State, Local,
or Tribal Governments; Number of Respondents: 800; Number of Responses:
48,439; Total Burden Hours: 33,419.50. (For questions regarding this
collection contact Elizabeth Jacob at 410-786-8658).
2. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Bid Pricing Tool
(BPT) for Medicare Advantage (MA) Plans and Prescription Drug Plans
(PDP); Use: Medicare Advantage organizations (MAO) and Prescription
Drug Plans (PDP) are required to submit an actuarial pricing ``bid''
for each plan offered to Medicare beneficiaries for approval by CMS.
The MAOs and PDPs use the Bid Pricing Tool (BPT) software to develop
their actuarial pricing bid. The competitive bidding process defined by
the ``The Medicare Prescription Drug, Improvement, and Modernization
Act'' (MMA) applies to both the MA and Part D programs. It is an annual
process that encompasses the release of the MA rate book in April, the
bid's that plans submit to CMS in June, and the release of the Part D
and RPPO benchmarks, which typically occurs in August. Form number:
CMS-10142 (OMB control number: 0938-0944); Frequency: Annually;
Affected Public: Private Sector, Business or other for-profits, Not-
for-profit institutions; Number of Respondents: 555; Number of
Responses: 4,995; Total Burden Hours: 149,850. (For questions regarding
this collection contact Rachel Shevland at 410-786-3026).
Dated: September 30, 2022.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2022-21657 Filed 10-4-22; 8:45 am]
BILLING CODE 4120-01-P